Price Alert

Viking Therapeutics Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

25.20

0.11 (0.44%)

At close: Sep 26, 2025, 11:05 AM

0.44% (1D)

Bid	25.19
Market Cap	2.83B
Revenue (ttm)	n/a
Net Income (ttm)	-171.55M
EPS (ttm)	-1.54
PE Ratio (ttm)	-16.36
Forward PE	-8.51
Analyst	Buy
Dividends	n/a

Ask	25.23
Volume	912,694
Avg. Volume (20D)	6,242,617
Open	25.29
Previous Close	25.09
Day's Range	24.88 - 25.41
52-Week Range	18.92 - 81.73
Beta	0.72
Ex-Dividend Date	n/a

About VKTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VKTX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

-42.12%

Viking Therapeutics shares are trading lower follo... Unlock content with Pro Subscription

1 month ago

-42.12%

VKTX stock has given up its prior gain. Viking Therapeutics shares were trading higher after the company's obesity drug showed up to 12% weight loss in a Phase 2 trial.

News

22 hours ago · zacks.com

Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $25.09, indicating a -5.78% shift from the previous trading day.

18 hours ago · zacks.com

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

18 hours ago · zacks.com

Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up?

VKTX faces rising pressure in the obesity drug race as Pfizer re-enters with a $4.9B Metsera deal and rivals scale up.

2 days ago · zacks.com

Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $24.97, denoting a -4.88% move from the preceding trading day.

3 days ago · seekingalpha.com

Viking Therapeutics, Inc. (VKTX) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript

Viking Therapeutics, Inc. (NASDAQ:VKTX ) Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 11:20 AM EDT Company Participants Brian Lian - President, CEO & Director Conference Call P...

4 days ago · seekingalpha.com

Viking Therapeutics, Inc. (VKTX) Q4 2023 Earnings Call Transcript

Viking Therapeutics, Inc. (NASDAQ:VKTX ) Q4 2023 Earnings Conference Call February 7, 2024 4:30 PM ET Company Participants Brian Lian - President and CEO Greg Zante - CFO Stephanie Diaz - Manager of I...

1 week ago · fool.com

Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months

The late investing legend Charlie Munger talked about a "fat-pitch strategy," a baseball analogy about waiting for a big, no-brainer opportunity you can take advantage of. When you get that fat pitch,...

1 week ago · marketbeat.com

Biotech Breakouts: 3 Stocks With Massive Upside Potential

Investing in biotechnology stocks is complex due to the science behind the company's drug candidates. They can be difficult to trade because these stocks are highly volatile, with double-digit moves i...